Harnessing cell cycle synchronization to boost the therapeutic potential of umbilical cord MSCs against acute colitis
Researchers are investigating whether synchronizing the cell cycle of umbilical cord mesenchymal stromal cells (UCMSCs) can improve their therapeutic effectiveness in treating acute colitis. By using serum starvation and double thymidine blocks, the study aims to optimize the immunomodulatory capacity of these stem cells in mouse models.
Why it matters
Advancing stem cell therapy protocols could lead to more effective treatments for inflammatory bowel diseases and other autoimmune conditions.
Scientific Reports ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in